Suppr超能文献

雌激素维持雌性高血压大鼠小动脉中的一氧化氮合成。

Estrogen maintains nitric oxide synthesis in arterioles of female hypertensive rats.

作者信息

Huang A, Sun D, Kaley G, Koller A

机构信息

Department of Physiology, New York Medical College, Valhalla 10595, USA.

出版信息

Hypertension. 1997 Jun;29(6):1351-6. doi: 10.1161/01.hyp.29.6.1351.

Abstract

We hypothesized that in female spontaneously hypertensive rats (SHR), estrogen moderates the dysfunction of arterioles by preserving nitric oxide synthesis. To this end, we conducted experiments on isolated gracilis muscle arterioles (approximately 55 microns in diameter) of 12-week-old (SHR divided into four groups: females (fSHR), ovariectomized females (fSHR-OV), ovariectomized females with estrogen replacement (fSHR-OV+ES, 50 micrograms/kg SC 17 beta-estradiol benzoate every 48 hours), and males (mSHR). Arteriolar diameter in the presence of perfusion pressures of 60, 80, 100, and 120 mm Hg were obtained, and diameter changes were measured (at 80 mm Hg) in response to various concentrations of substance P (10(-9) to 5 x 10(-8) mol/L), sodium nitroprusside (10(-8) to 10(-6) mol/L), and A23187 (5 x 10(-8) to 10(-6) mol/L). The pressure-induced diameter of mSHR and fSHR-OV arterioles was significantly less (by approximately 10%) than that of fSHR and fSHR-OV+ES arterioles. N omega-nitro-L-arginine (10(-4) mol/L), a nitric oxide synthase inhibitor, elicited a significant decrease in basal arteriolar diameter of fSHR (by approximately 19%) and fSHR-OV+ES (by approximately 17%), thereby eliminating the differences in tone among the various groups. Dilations of fSHR and fSHR-OV+ES arterioles to substance P were significantly greater (by 140% at a concentration of 5 x 10(-8) mol/L) than those of mSHR and fSHR-OV arterioles, whereas dilations to sodium nitroprusside were not different among the groups. A23187 (a nitric oxide releaser) elicited dilations in arterioles of fSHR (5.9 +/- 1.5%, 13.0 +/- 1.8%, and 19.2 +/- 2.1%) and fSHR-OV+ES (4.3 +/- 1.0%, 10.3 +/- 2.4%, and 15.0 +/- 4.0%) but constrictions in those of mSHR (-7.5 +/- 1.6%, -25.3 +/- 39%, and -36.9 +/- 4.1%) and fSHR-OV (-2.6 +/- 1.7%, 7.4 +/- 3.3%, and -11.5 +/- 6.1%). We conclude that estrogen in fSHR is responsible for the preservation of nitric oxide synthesis in skeletal muscle arterioles, resulting in a greater modulation of pressure-induced myogenic tone than in mSHR and maintenance of nitric oxide-mediated dilations.

摘要

我们假设,在雌性自发性高血压大鼠(SHR)中,雌激素通过维持一氧化氮合成来减轻小动脉功能障碍。为此,我们对12周龄SHR的离体股薄肌小动脉(直径约55微米)进行了实验,将SHR分为四组:雌性(fSHR)、去卵巢雌性(fSHR - OV)、接受雌激素替代的去卵巢雌性(fSHR - OV + ES,每48小时皮下注射50微克/千克17β - 雌二醇苯甲酸酯)和雄性(mSHR)。获取在60、80、100和120毫米汞柱灌注压力下的小动脉直径,并测量(在80毫米汞柱时)对不同浓度的P物质(10⁻⁹至5×10⁻⁸摩尔/升)、硝普钠(10⁻⁸至10⁻⁶摩尔/升)和A23187(5×10⁻⁸至10⁻⁶摩尔/升)的直径变化。mSHR和fSHR - OV小动脉的压力诱导直径明显小于fSHR和fSHR - OV + ES小动脉(约小10%)。一氧化氮合酶抑制剂Nω - 硝基 - L - 精氨酸(10⁻⁴摩尔/升)使fSHR(约19%)和fSHR - OV + ES(约17%)的基础小动脉直径显著减小,从而消除了各组之间的张力差异。fSHR和fSHR - OV + ES小动脉对P物质的舒张作用明显大于mSHR和fSHR - OV小动脉(在5×10⁻⁸摩尔/升浓度下大140%),而对硝普钠的舒张作用在各组之间无差异。A23187(一种一氧化氮释放剂)引起fSHR(5.9±1.5%、13.0±1.8%和19.2±2.1%)和fSHR - OV + ES(4.3±1.0%、10.3±2.4%和15.0±4.0%)小动脉舒张,但引起mSHR( - 7.5±1.6%、 - 25.3±3.9%和 - 36.9±4.1%)和fSHR - OV( - 2.6±1.7%、7.4±3.3%和 - 11.5±6.1%)小动脉收缩。我们得出结论,fSHR中的雌激素负责维持骨骼肌小动脉中的一氧化氮合成,导致对压力诱导的肌源性张力的调节比mSHR更大,并维持一氧化氮介导的舒张作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验